Mouse PD-1 Antibody AF1021: R&D Systems
Anti-PD-1 Neutralizing Antibody
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion | Nature Communications
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
PD-L1 Neutralizing Antibody
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
Human PD-L1 Antibody (PDL1.D1), mAb, Mouse - GenScript
A. C57BL/6 mice were intraperitoneally treated with an anti-PD-1... | Download Scientific Diagram
Anti-Mouse CD279 Clone 29F.1A12 (PD-1) - In vivo Functional Grade
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade | Nature Communications
Bio X Cell - PD1 Antibodies
A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies | Scientific Reports
Cancers | Free Full-Text | Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain | HTML
Bio X Cell - InVivoPlus anti-mouse PD-1 (CD279)
Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy | Journal for ImmunoTherapy of Cancer | Full Text
Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells | BMC Cancer | Full Text
Human PD-1 Antibody (PD1.D3), mAb, Mouse - GenScript
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells | Clinical Cancer Research
PD-1/PD-L1 interaction blocked by antibodies, freeing T cell to kill tumor cell - FineTest ELISA Kit | FineTest Antibody | Wuhan Fine Biotech Co., Ltd.
PD‐1‐specific “Blocking” antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments - Polesso - 2021 - European Journal of Immunology - Wiley Online Library
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake | Pharmacology
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
Anti-PD-1 Blocking Antibody Inhibits Human Melanoma Xenograft Growth in... | Download Scientific Diagram
